VOYA INVESTMENT MANAGEMENT LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1068837
ATLANTA, GA
Position in NBIX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$11,432,001
-$1,423,470 QoQ
Shares Held
86,777
-4.3% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 74.49785081300344.ToString("F0")%
None 25.502149186996554.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VOYA INVESTMENT MANAGEMENT LLC holds $107,185,058 across 26 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
336,987 | $25,560,463 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
24,488 | $14,520,894 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
558,662 | $13,368,781 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
86,777 | $11,432,001 | |
| 5 | ZTS |
Zoetis Inc.
|
83,493 | $9,869,707 | |
| 6 | VTRS |
Viatris Inc
|
519,568 | $7,019,363 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
536,304 | $5,105,613 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
145,045 | $4,368,755 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,432,001 | 86,777 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $12,855,471 | 90,640 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $12,813,605 | 91,278 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $15,301,500 | 121,740 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $16,462,257 | 148,845 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $19,033,696 | 139,441 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $14,179,894 | 123,068 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $20,854,389 | 151,481 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $20,547,735 | 148,983 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $17,754,132 | 134,746 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $20,091,261 | 178,589 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $16,105,024 | 170,785 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $16,750,694 | 165,488 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $19,326,704 | 161,811 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $13,281,559 | 125,050 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $7,862,931 | 80,662 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,684,656 | 71,303 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,399,948 | 63,402 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,765,618 | 39,262 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,909,539 | 40,172 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,989,659 | 30,742 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,110,236 | 32,449 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,281,171 | 34,122 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,330,146 | 35,493 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,827,415 | 32,668 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||